Wolverine Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Wolverine Asset Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-27,431	Closed	-$1.87M	–	2846
2022 Q3	$1.87M	Buy	+27,431	New	+$1.51M	0.02%	592
2021 Q2	–	Sell	-122	Closed	-$4K	–	2536
2021 Q1	$4K	Sell	122 -2,661	-96%	-$122K	﹤0.01%	1951
2020 Q4	$120K	Buy	+2,783	New	+$137K	﹤0.01%	1183
2020 Q3	–	Sell	-31	Closed	-$1K	–	1855
2020 Q2	$1K	Buy	+31	New	+$2.13K	﹤0.01%	1505

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Wolverine Asset Management's GBT Position: Q4 2022 in Review

Wolverine Asset Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 27,431 shares — an estimated $1.87M sold.

Wolverine Asset Management first reported a position in GBT in Q2 2020 and held it in 4 quarters. The position peaked at $1.87M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Wolverine Asset Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Wolverine Asset Management sold 27,431 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $1.87M.
Wolverine Asset Management first reported a position in Global Blood Therapeutics, Inc. in Q2 2020 and held it in 4 quarters.
Wolverine Asset Management's Global Blood Therapeutics, Inc. position peaked at $1.87M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Wolverine Asset Management's 13F filing for Q4 2022, filed 1 Feb 2023.